Biomarkers Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biomarkers market
Biomarkers Market: Types (Biomarkers: Disease & related, Imaging, Others) Application (Drug Discovery, Bioinformatics, Others) Therapeutic Areas (Cardiology, Neurology, Others) Products (Hormones, Enzymes, Others) End Users (Hospitals, Others)-Forecast(2018-2023)
Report Code : HCR 0059
Updated Date: 17 October, 2018  
6

Copies sold

    Client Rating

1. Biomarkers Market - Overview
1.1. Definitions and Scope
2. Biomarkers Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Biomarkers Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Biomarkers Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Biomarkers Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Biomarkers Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Biomarkers Market - Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Biomarkers Market – By Types (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Disease-related biomarkers
8.3.1.1. Diagnostic biomarker
8.3.1.2. Prognostic biomarker
8.3.2. Drug-related biomarkers
8.3.3. Imaging biomarkers
8.3.4. Molecular biomarkers
8.3.5. Surrogate biomarkers
8.3.6. Others
9. Biomarkers Market – By Application (Market Size -$Million / $Billion)
9.1. Drug discovery & Development
9.2. Molecular diagnostics
9.3. Genetic studies
9.4. Clinical Trials
9.5. Bioinformatics
9.6. Others
10. Biomarkers Market – By Therapeutic areas (Market Size -$Million / $Billion)
10.1. Oncology
10.2. Cardiology
10.3. Immunology
10.4. Neurology
10.5. Others
11. Biomarkers Market – By Products (Market Size -$Million / $Billion)
11.1. Hormones
11.2. Enzymes
11.3. Antibodies
11.4. Gene products
11.5. Gene products
12. Biomarkers – By End Use Industry(Market Size -$Million / $Billion)
12.1. Segment type Size and Market Share Analysis 
12.2. Application Revenue and Trends by type of Application
12.3. Application Segment Analysis by Type
12.3.1. Pharmaceutical Companies
12.3.2. Hospitals
12.3.3. Research Institutes
12.3.4. CROs
12.3.5. Diagnostic Labs
13. Biomarkers - By Geography (Market Size -$Million / $Billion)
13.1. Biomarkers Market - North America Segment Research
13.2. North America Market Research (Million / $Billion)
13.2.1. Segment type Size and Market Size Analysis 
13.2.2. Revenue and Trends
13.2.3. Application Revenue and Trends by type of Application
13.2.4. Company Revenue and Product Analysis
13.2.5. North America Product type and Application Market Size
13.2.5.1. U.S.
13.2.5.2. Canada 
13.2.5.3. Mexico 
13.2.5.4. Rest of North America
13.3. Biomarkers - South America Segment Research
13.4. South America Market Research (Market Size -$Million / $Billion)
13.4.1. Segment type Size and Market Size Analysis 
13.4.2. Revenue and Trends
13.4.3. Application Revenue and Trends by type of Application
13.4.4. Company Revenue and Product Analysis
13.4.5. South America Product type and Application Market Size
13.4.5.1. Brazil  
13.4.5.2. Venezuela
13.4.5.3. Argentina
13.4.5.4. Ecuador
13.4.5.5. Peru
13.4.5.6. Colombia 
13.4.5.7. Costa Rica
13.4.5.8. Rest of South America
13.5. Biomarkers - Europe Segment Research
13.6. Europe Market Research (Market Size -$Million / $Billion)
13.6.1. Segment type Size and Market Size Analysis 
13.6.2. Revenue and Trends
13.6.3. Application Revenue and Trends by type of Application
13.6.4. Company Revenue and Product Analysis
13.6.5. Europe Segment Product type and Application Market Size
13.6.5.1. U.K  
13.6.5.2. Germany 
13.6.5.3. Italy 
13.6.5.4. France
13.6.5.5. Netherlands
13.6.5.6. Belgium
13.6.5.7. Spain
13.6.5.8. Denmark
13.6.5.9. Rest of Europe
13.7. Biomarkers – APAC Segment Research
13.8. APAC Market Research (Market Size -$Million / $Billion)
13.8.1. Segment type Size and Market Size Analysis 
13.8.2. Revenue and Trends
13.8.3. Application Revenue and Trends by type of Application
13.8.4. Company Revenue and Product Analysis
13.8.5. APAC Segment – Product type and Application Market Size
13.8.5.1. China 
13.8.5.2. Australia
13.8.5.3. Japan 
13.8.5.4. South Korea
13.8.5.5. India
13.8.5.6. Taiwan
13.8.5.7. Malaysia
14. Biomarkers Market - Entropy
14.1. New product launches
14.2. M&A's, collaborations, JVs and partnerships
15. Biomarkers Market – Industry / Segment Competition landscape
15.1. Market Share Analysis
15.1.1. Market Share by Country- Top companies
15.1.2. Market Share by Region- Top 10 companies
15.1.3. Market Share by type of Application – Top 10 companies
15.1.4. Market Share by type of Product / Product category- Top 10 companies
15.1.5. Market Share at global level- Top 10 companies
15.1.6. Best Practises for companies
16. Biomarkers Market – Key Company List by Country
17. Biomarkers Market Company Analysis
17.1. Market Share, Company Revenue, Products, M&A, Developments
17.2. Qiagen N.V.
17.3. PerkinElmer, Inc.
17.4. Merck & Co, Inc.
17.5. Bio-Rad Laboratories
17.6. Enzo Biochem
17.7. EKF Diagnostics Holdings plc
17.8. Meso Scale Diagnostics, LLC
17.9. Singulex, Inc.
17.10. BioSims Technologies
17.11. Cisbio Bioassays
17.12. Signosis, Inc.
17.13. Roche Diagnostic Limited
17.14. Siemens Healthcare
17.15. Abbott Laboratories Inc.
17.16. Thermo Fisher Scientific, Inc.
17.17. Agilent Technologies Inc.
17.18. Aushon BioSystem Inc.
17.19. Epistem Ltd
17.20. G.E. Healthcare Inc.
17.21. Beckman Coulter, Inc.
17.22. Biomoda, Inc.
17.23. Company 22
17.24.Company 22
17.25. Company 22 and more
"*Financials would be provided on a best efforts basis for private companies"
18. Biomarkers Market - Appendix
18.1. Abbreviations
18.2. Sources
19. Biomarkers Market - Methodology
19.1. Research Methodology
19.1.1. Company Expert Interviews
19.1.2. Industry Databases
19.1.3. Associations
19.1.4. Company News
19.1.5. Company Annual Reports
19.1.6. Application Trends
19.1.7. New Products and Product database
19.1.8. Company Transcripts
19.1.9. R&D Trends
19.1.10. Key Opinion Leaders Interviews
19.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll